Goldman Sachs Group Inc Stoke Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,368,967 shares of STOK stock, worth $9.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,368,967
Previous 1,393,760 1.78%
Holding current value
$9.87 Million
Previous $17.1 Million 11.85%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$10.8 - $13.92 $267,764 - $345,118
-24,793 Reduced 1.78%
1,368,967 $15.1 Million
Q3 2024

Nov 14, 2024
BUY
$12.24 - $15.92 $321,214 - $417,788
26,243 Added 1.92%
1,393,760 $17.1 Million
Q2 2024

Aug 13, 2024
SELL
$11.03 - $17.52 $403,014 - $640,145
-36,538 Reduced 2.6%
1,367,517 $18.5 Million
Q1 2024

May 15, 2024
BUY
$4.12 - $14.17 $52,010 - $178,882
12,624 Added 0.91%
1,404,055 $19 Million
Q4 2023

Feb 13, 2024
BUY
$3.37 - $5.4 $4.25 Million - $6.82 Million
1,262,126 Added 976.08%
1,391,431 $7.32 Million
Q3 2023

May 14, 2024
SELL
$3.78 - $11.99 $4.77 Million - $15.1 Million
-1,262,126 Reduced 90.71%
129,305 $509,000
Q3 2023

Nov 14, 2023
BUY
$3.78 - $11.99 $135,339 - $429,289
35,804 Added 38.29%
129,305 $509,000
Q2 2023

May 14, 2024
BUY
$7.93 - $13.82 $89,838 - $156,566
11,329 Added 13.79%
93,501 $993,000
Q2 2023

Aug 14, 2023
BUY
$7.93 - $13.82 $89,838 - $156,566
11,329 Added 13.79%
93,501 $993,000
Q1 2023

May 14, 2024
BUY
$7.65 - $10.38 $109,471 - $148,537
14,310 Added 21.09%
82,172 $684,000
Q1 2023

May 11, 2023
BUY
$7.65 - $10.38 $109,471 - $148,537
14,310 Added 21.09%
82,172 $684,000
Q4 2022

May 14, 2024
SELL
$7.07 - $15.69 $313,936 - $696,698
-44,404 Reduced 39.55%
67,862 $626,000
Q4 2022

Feb 13, 2023
SELL
$7.07 - $15.69 $313,936 - $696,698
-44,404 Reduced 39.55%
67,862 $626,000
Q3 2022

May 14, 2024
SELL
$12.56 - $22.53 $119,583 - $214,508
-9,521 Reduced 7.82%
112,266 $1.44 Million
Q3 2022

Nov 10, 2022
SELL
$12.56 - $22.53 $119,583 - $214,508
-9,521 Reduced 7.82%
112,266 $1.44 Million
Q2 2022

May 14, 2024
SELL
$10.36 - $23.93 $13.2 Million - $30.4 Million
-1,269,644 Reduced 91.25%
121,787 $1.61 Million
Q2 2022

Aug 15, 2022
BUY
$10.36 - $23.93 $80,238 - $185,337
7,745 Added 6.79%
121,787 $1.61 Million
Q1 2022

May 16, 2022
SELL
$17.19 - $26.1 $211,247 - $320,742
-12,289 Reduced 9.73%
114,042 $2.4 Million
Q4 2021

Feb 14, 2022
SELL
$18.11 - $30.72 $840,629 - $1.43 Million
-46,418 Reduced 26.87%
126,331 $3.03 Million
Q3 2021

Nov 10, 2021
BUY
$23.65 - $34.44 $4.09 Million - $5.95 Million
172,749 New
172,749 $4.4 Million

Others Institutions Holding STOK

# of Institutions
135
Shares Held
57.2M
Call Options Held
5.7K
Put Options Held
24.4K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $284M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email